Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Novus Scientific AB
AB
Active
Org 5567745442
Virdings Allé 2, 754 50
Uppsala
Manufacture of medical and dental instruments and supplies
·
NACE 3250
Est. 2008 · 17 years old
20-49 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of medical and dental instruments and supplies
/
Novus Scientific AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
55M
41M
27M
14M
0M
2020: 17M
17M
2020
2021: 18M (+6% vs 2020)
18M
+6%
2021
2022: 22M (+22% vs 2021)
22M
+22%
2022
2023: 34M (+55% vs 2022)
34M
+55%
2023
2024: 44M (+29% vs 2023)
44M
+29%
2024
EBITDA
SEK millions
21M
12M
4M
-5M
-14M
2020: -6M
-6M
2020
2021: -7M (-17% vs 2020)
-7M
-17%
2021
2022: -6M (+14% vs 2021)
-6M
+14%
2022
2023: 7M (+217% vs 2022)
7M
+217%
2023
2024: 14M (+100% vs 2023)
14M
+100%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
44 205
34 377
21 768
17 906
17 131
Staff expenses
—
—
—
—
—
EBITDA
14 470
6 957
−6 426
−7 261
−5 944
Depreciation & amort.
−339
−412
−315
−342
−376
EBIT
14 131
6 545
−6 741
−7 603
−6 320
Net financials
−10 391
1 214
803
474
−570
Profit before tax
3 740
7 759
−5 939
−7 128
−6 891
Tax
−2 814
−0
−0
−0
−0
Net profit
926
7 759
−5 939
−7 128
−6 891
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
47 645
45 596
37 885
28 932
25 435
Equity
13 130
12 204
4 445
5 384
2 512
Long-term debt
0
0
0
0
0
Short-term debt
34 515
33 392
33 440
23 548
22 923
Total debt
34 515
33 392
33 440
23 548
22 923
Financial ratios
5-year trend
EBITDA margin
32,7 %
This company
15,8 %
Market median
This company
Market median
107% above market
2020
2024
Equity ratio
27,6 %
This company
38,2 %
Market median
This company
Market median
28% below market
2020
2024
Return on equity
7,1 %
This company
18,4 %
Market median
This company
Market median
61% below market
2020
2024
Net profit margin
2,1 %
This company
8,1 %
Market median
This company
Market median
74% below market
2020
2024
Asset turnover
0,93×
This company
1,12×
Market median
This company
Market median
17% below market
2020
2024
Debt / equity
2,63×
This company
0,62×
Market median
This company
Market median
324% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Novus Scientific AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
